Form4insider filings, from the source

SEC Form 4 · accession 0001477932-15-000002

Innovation Pharmaceuticals Inc. · IPIX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Leo Ehrlich
Officer — Chief Executive Officer · Director · 10% Owner
Period of report
Dec 30, 2014
Accepted (ET)
Jan 2, 2015 · 10:22 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001355250

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Class A Common par value $0.0001F1Dec 30, 2014G50,000$0.00D8,585,002D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses